| 000 | 01885 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517150954.0 | ||
| 264 | 0 | _c20180309 | |
| 008 | 201803s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.16148 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPodhorecka, Monika | |
| 245 | 0 | 0 |
_aChanges in T-cell subpopulations and cytokine network during early period of ibrutinib therapy in chronic lymphocytic leukemia patients: the significant decrease in T regulatory cells number. _h[electronic resource] |
| 260 |
_bOncotarget _cMay 2017 |
||
| 300 |
_a34661-34669 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCytokines _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPiperidines |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aPyrazoles _xadministration & dosage |
| 650 | 0 | 4 |
_aPyrimidines _xadministration & dosage |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aT-Lymphocyte Subsets _xdrug effects |
| 650 | 0 | 4 |
_aT-Lymphocytes, Regulatory _xdrug effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aGoracy, Aneta | |
| 700 | 1 | _aSzymczyk, Agnieszka | |
| 700 | 1 | _aKowal, Malgorzata | |
| 700 | 1 | _aIbanez, Blanca | |
| 700 | 1 | _aJankowska-Lecka, Olga | |
| 700 | 1 | _aMacheta, Arkadiusz | |
| 700 | 1 | _aNowaczynska, Aleksandra | |
| 700 | 1 | _aDrab-Urbanek, Elzbieta | |
| 700 | 1 | _aChocholska, Sylwia | |
| 700 | 1 | _aJawniak, Dariusz | |
| 700 | 1 | _aHus, Marek | |
| 773 | 0 |
_tOncotarget _gvol. 8 _gno. 21 _gp. 34661-34669 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.16148 _zAvailable from publisher's website |
| 999 |
_c27088129 _d27088129 |
||